drugset / Trial / NCT01240148

Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers

NCT01240148

Phase 1 Completed 26 enrolled AstraZeneca
RandomizedSingle-groupDouble-blindBasic science

Summary

The purpose of this study is to investigate the effect of AZD3161 on mechanical pain sensitivity and axon reflex flare in normal and ultraviolet C irradiated skin.

Timeline

Start
2010-12
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD3161 Unknown 1 unknown Other
Subject AZD3161 Unknown 6 unknown Other
Subject AZD3161 Unknown 30 unknown Other
Comparator Lidocaine Other / unclassified 10 mg/ml Other

Indications